Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

BackgroundNon–small cell lung cancer (NSCLC) has entered the era of immunotherapy. However, only partial patients were able to benefit from immune checkpoint inhibitors (ICIs). Currently, biomarkers for predicting patients’ response to ICIs are primarily tumor tissue dependent and have limited accur...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kang Miao, Xiaotong Zhang, Hanping Wang, Xiaoyan Si, Jun Ni, Wei Zhong, Jing Zhao, Yan Xu, Minjiang Chen, Ruili Pan, Mengzhao Wang, Li Zhang
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-07-01
Col·lecció:	Frontiers in Immunology
Matèries:	immune checkpoint inhibitors (ICIs) lymphocyte subsets CD4+CD45RA− T cell biomarker CD8+CD38+ T cell
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.912180/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!